Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetyana Klymenko

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
EMBO Reports|March 20, 2004
The histone methyltransferases Trithorax and Ash1 prevent transcriptional silencing by Polycomb group proteinsTetyana Klymenko, Jürg Müller
Biochemical Society Transactions|July 24, 2012
Human papillomavirus gene expression is controlled by host cell splicing factorsTetyana Klymenko, Sheila V Graham
Protein Science : a Publication of the Protein Society|July 30, 2010
Structure of an atypical Tudor domain in the Drosophila Polycomblike proteinAnders Friberg, Anna Oddone, Tetyana Klymenko, et al.
Molecular Cancer Therapeutics|October 19, 2011
The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia and is able to reverse hypoxia-induced drug resistance in neuroblastoma cellsTetyana Klymenko, Martin Brandenburg, Christopher Morrow, et al.
Hybridoma (2005)|August 12, 2009
Generation of monoclonal antibody targeting fibroblast growth factor receptor 3Olena Gorbenko, Galyna Ovcharenko, Tetyana Klymenko, et al.
Genes & Development|April 19, 2006
A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activitiesTetyana Klymenko, Bernadett Papp, Wolfgang Fischle, et al.
The EMBO Journal|September 1, 2007
Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genesMaxim Nekrasov, Tetyana Klymenko, Sven Fraterman, et al.
Experimental Cell Research|May 12, 2010
Up-regulation of the embryonic self-renewal network through reversible polyploidy in irradiated p53-mutant tumour cellsKristine Salmina, Eriks Jankevics, Anda Huna, et al.
Iscience|February 22, 2021
Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathwaysJennifer Edelmann, Arran D Dokal, Emma Vilventhraraja, et al.
AIDS (London, England)|June 18, 2013
Natural NS3 resistance polymorphisms occur frequently prior to treatment in HIV-positive patients with acute hepatitis CMayke Leggewie, Vattipally B Sreenu, Tamer Abdelrahman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
EMBO Reports|March 20, 2004
The histone methyltransferases Trithorax and Ash1 prevent transcriptional silencing by Polycomb group proteinsTetyana Klymenko, Jürg Müller
Biochemical Society Transactions|July 24, 2012
Human papillomavirus gene expression is controlled by host cell splicing factorsTetyana Klymenko, Sheila V Graham
Protein Science : a Publication of the Protein Society|July 30, 2010
Structure of an atypical Tudor domain in the Drosophila Polycomblike proteinAnders Friberg, Anna Oddone, Tetyana Klymenko, et al.
Molecular Cancer Therapeutics|October 19, 2011
The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia and is able to reverse hypoxia-induced drug resistance in neuroblastoma cellsTetyana Klymenko, Martin Brandenburg, Christopher Morrow, et al.
Hybridoma (2005)|August 12, 2009
Generation of monoclonal antibody targeting fibroblast growth factor receptor 3Olena Gorbenko, Galyna Ovcharenko, Tetyana Klymenko, et al.
Genes & Development|April 19, 2006
A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activitiesTetyana Klymenko, Bernadett Papp, Wolfgang Fischle, et al.
The EMBO Journal|September 1, 2007
Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genesMaxim Nekrasov, Tetyana Klymenko, Sven Fraterman, et al.
Experimental Cell Research|May 12, 2010
Up-regulation of the embryonic self-renewal network through reversible polyploidy in irradiated p53-mutant tumour cellsKristine Salmina, Eriks Jankevics, Anda Huna, et al.
Iscience|February 22, 2021
Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathwaysJennifer Edelmann, Arran D Dokal, Emma Vilventhraraja, et al.
AIDS (London, England)|June 18, 2013
Natural NS3 resistance polymorphisms occur frequently prior to treatment in HIV-positive patients with acute hepatitis CMayke Leggewie, Vattipally B Sreenu, Tamer Abdelrahman, et al.
Pageof 2